Abstract
Substance use disorders are prevalent worldwide and may lead to a wide range of physical, psychological and emotional health problems in Ghana. There has been an increase in the use of illicit drugs in the past decade. The present study examined the relationships among depression, purpose in life (PIL), loneliness and anxiety with patients diagnosed with substance use disorders (SUDs) in Ankaful Psychiatric Hospital in Ghana. This descriptive and correlational design was conducted among 200 patients using socio-demographic data, Beck Depression Inventory-II, PIL, Revised University of California Los Angeles Loneliness Scale (R-UCLA) and beck anxiety inventory. Data were collected from April 15 to May 30, 2019 and were analyzed using spearman partial correlations, one-way ANOVA, Kruskal–Wallis ANOVA and hierarchical regression. A total of 192 participants completed the survey instruments. The results revealed that purpose in life had a significant negative relationship with depression and anxiety. Depression had a significant direct correlation with anxiety. For loneliness, there was no difference between gender, but a significant finding was found among marital status. For all other dependent variables, purpose in life, depression and anxiety, there were no statistically significant findings. Purpose in life is the only predictor of depression of participants. These findings indicate that patients diagnosed with SUDs have additional psychological and mental health concerns. While treating SUD, mental health professionals should identify and manage those problems too. This may help better management plan for patients with SUD.
Similar content being viewed by others
References
DSM-5 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing; 2013.
Lopez-Quintero C, de Los Cobos JP, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1–2):120–30.
Wagner FA, Anthony JC. From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002;26(4):479–88.
Poudel A, Sharma C, Gautam S, Poudel A. Psychosocial problems among individuals with substance use disorders in drug rehabilitation centers, Nepal. Subst Abuse Treat Prev Policy. 2016;11(1):28.
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.
Ofori-Atta A, Read UM, Lund C, MHaPP Research Programme Consortium. A situation analysis of mental health services and legislation in Ghana: challenges for transformation. Afr J Psychiatry. 2010;13(2):99–108.
Boachie PA. Medical systems in Ghana. Accra: Ghana Publishing; 2005.
Johnson W. Factors influencing drug abuse among student clients of Ankaful psychiatric hospital in the Cape Coast Metropolis. Doctoral dissertation, University of Cape Coast; 2012.
Out-Patient Monthly Morbidity Returns. Psychiatric Unit: Regional Hospital, Sunyani; 2016.
Bryant KJ, Rounsaville B, Spitzer RL, Williams JB. Reliability of dual diagnosis: substance dependence and psychiatric disorders. J Ment Nerv Disord. 1992;180(4):251–7.
El-Guebaly N. Substance use disorders and mental illness: the relevance of comorbidity. Can J Psychiat. 1995;40(1):2–3.
Smith J, Hucker S. Schizophrenia and substance abuse. Br J Psychiatry. 1994;165(1):13–21.
Weiss RD, Mirin SM, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers. Br J Addict. 1992;87(2):179–87.
Kessler RC, Wang PS. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health. 2008;29:115–29.
Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. J Am Med Assoc. 1990;264(19):2511–8.
Yilmaz O, Dilbaz N. Complex comorbidity of substance use disorders with anxiety disorders: diagnosis and treatment. New Dev Anxiety Disord. 2016;2016:89–107.
Mueser KT, Rosenberg SD, Drake RE, Miles KM, Wolford G, Vidaver R, Carrieri K. Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. J Stud Alcohol. 1999;60(2):278–84.
Kaplan HI, Sadock BJ, Grebb JA. Synopsis of psychiatry. Philadelphia: Williams & Wilkins; 1994. p. 383–456.
Oyefeso A, Ghodse H, Clancy C, Corkefy JM. Suicide among drug addicts in the United Kingdom. Br J Psychiatry. 1999;175(3):277–82.
Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43–51.
Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry. 1990;147(6):685–95.
Carpentier PJ, Krabbe PF, Van Gogh MT, Knapen LJ, Buitelaar JK, De Jong CA. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict. 2009;18(6):470–80.
Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375–80.
Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow- up. J Affect Disord. 2009;115(1–2):27–35.
Galaif ER, Sussman S, Newcomb MD, Locke TF. Suicidality, depression, and alcohol use among adolescents: a review of empirical findings. Int J Adolesc Med Health. 2007;19(1):27–36.
Åkerlind I, Hörnquist JO. Loneliness and alcohol abuse: a review of evidences of an interplay. Soc Sci Med. 1992;34(4):405–14.
Clinebell HJ Jr. Philosophical-religious factors in the etiology and treatment of alcoholism. Q J Stud Alcohol. 1963;24(3):473–88.
Kurtz E. Not-God: a history of alcoholics anonymous center city. New York: Hazelden Educational Services; 1979.
Crumbaugh JC, Maholick LT. Manual of instructions for the purpose in life Test. Munster: Psychometrics Affiliates; 1969.
Beck AT, Steer RA, Brown GK. Manual for the beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
Russell D, Peplau LA, Cutrona CE. The revised UCLA loneliness scale: concurrent and discriminant validity evidence. J Pers Soc Psychol. 1980;39(3):472–80.
Frankl VE. The doctor and the soul. New York: Vintage; 1959.
Cutrona CE. Nonpsychotic postpartum depression: a review of recent research. Clin Psychol Rev. 1982;2(4):487–503.
Kim O, Byeon YS, Kim JH, Endo E, Akahoshi M, Ogasawara H. Loneliness, depression and health status of the institutionalized elderly in Korea and Japan. Asian Nurs Res. 2009;3(2):63–70.
Hedayati MM, Khazaei MM. An investigation of the relationship between depression, meaning in life and adult hope. Proc Soc Behav Sci. 2014;114:598–601.
Steger MF, Mann JR, Michels P, Cooper TC. Meaning in life, anxiety, depression, and general health among smoking cessation patients. J Psychosom Res. 2009;67(4):353–8.
Buchanan DM. Meaning-in-life, depression and suicide in older adults: a comparative survey study. Diss Abstr Int. 1994;54:4075.
Reker GT, Peacock EJ, Wong PT. Meaning and purpose in life and well-being: a life-span perspective. J Gerontol. 1987;42(1):44–9.
Steger MF, Frazier P. Meaning in life: one link in the chain from religiousness to well-being. J Couns Psychol. 2005;52(4):574–82.
Zika S, Chamberlain K. On the relation meaning in life and psychological well-being. Br J Psychol. 1992;83(1):133–45.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69–77.
Cannon MF, Weems CF. Do anxiety and depression cluster into distinct groups? A test of tripartite model predictions in a community sample of youth. Depress Anxiety. 2006;23(8):453–60. https://doi.org/10.1002/da.20215.
Jacobson NC, Newman MG. Avoidance mediates the relationship between anxiety and depression over a decade later. J Anxiety Disord. 2014;28(5):437–45. https://doi.org/10.1016/j.janxdis.2014.03.007.
Norton S, Cosco T, Doyle F, Done J, Sacker A. The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res. 2013;74(1):74–81. https://doi.org/10.1016/j.jpsychores.2012.10.010.
De Jong Gierveld J, Van Tilburg T. The De Jong Gierveld short scales for emotional and social loneliness: tested on data from 7 countries in the UN generations and gender surveys. Eur J Ageing. 2010;7(2):121–30.
Nolen-Hoeksema S, Hilt LM. Gender differences in depression. In: Gotlib IH, Hammen CL, editors. Handbook of depression. 2nd ed. New York, NY: Guilford Press; 2009. p. 386–404.
Ryff CD, Singer BH. The contours of positive human health. Psychol Inq. 1998;9(1):1–28.
Cacioppo JT, Hughes ME, Waite LJ, Hawkley LC, Thisted RA. Loneliness as a specific risk factor for depressive symptoms: cross-sectional and longitudinal analysis. Psychol Aging. 2006;21(1):140–51.
Springer RMB, Weaver AJ, Linderblatt RC, Naditch RB, Newman RA, Siritsky RN, VandeCreek L. Spirituality, depression, and loneliness among Jewish seniors residing in New York City. J Pastor Care Couns. 2003;57(3):305–18.
EMCDDA. Perspectives on drugs: comorbidity of substance use and mental health disorders in Europe. Luxembourg: Office for Official Publications of the European Union; 2016. Retrieved from https://www.emcdda.europa.eu/topics/pods/comorbidity-substance-usemental-disorders-europe.
Langås A-M, Malt UF, Opjordsmoen S. Comorbid mental disorders in substance users from a single catchment area—a clinical study. Biomed Central Psychiatry. 2011;11(1):25.
Acknowledgements
The authors acknowledge the Directorate of Research, Innovation and Consultancy, University of Cape Coast for funding the study (Grant No. RSG/GRP/CES/2018/10). The authors appreciate the study institution, Ankaful Psychiatric hospital and the study participants, for their cooperation in providing all necessary information.
Author information
Authors and Affiliations
Contributions
AN conceived the study and was involved in the study design, reviewed the article, analysis, report writing and drafted the manuscript. JN was involved in the study design, analysis and drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nkyi, A.K., Ninnoni, J.P.K. Depression, Purpose in Life, Loneliness and Anxiety Among Patients with Substance Use Disorders in Ankaful Psychiatric Hospital in Ghana. J. Psychosoc. Rehabil. Ment. Health 7, 263–271 (2020). https://doi.org/10.1007/s40737-020-00190-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40737-020-00190-9